Komazec, T.; Bovan, D.; Kaluđerović, G.N.; Mihajlović, E.; Predarska, I.; Dunđerović, D.; Hey-Hawkins, E.; Mijatović, S.; Maksimović-Ivanić, D.
Hybrid Platinum(IV)-Naproxen Nanostructured Drugs Reprogram Melanoma Cells and Overpower Cisplatin. Nanomaterials 2025, 15, 1320.
https://doi.org/10.3390/nano15171320
AMA Style
Komazec T, Bovan D, Kaluđerović GN, Mihajlović E, Predarska I, Dunđerović D, Hey-Hawkins E, Mijatović S, Maksimović-Ivanić D.
Hybrid Platinum(IV)-Naproxen Nanostructured Drugs Reprogram Melanoma Cells and Overpower Cisplatin. Nanomaterials. 2025; 15(17):1320.
https://doi.org/10.3390/nano15171320
Chicago/Turabian Style
Komazec, Teodora, Dijana Bovan, Goran N. Kaluđerović, Ekatarina Mihajlović, Ivana Predarska, Duško Dunđerović, Evamarie Hey-Hawkins, Sanja Mijatović, and Danijela Maksimović-Ivanić.
2025. "Hybrid Platinum(IV)-Naproxen Nanostructured Drugs Reprogram Melanoma Cells and Overpower Cisplatin" Nanomaterials 15, no. 17: 1320.
https://doi.org/10.3390/nano15171320
APA Style
Komazec, T., Bovan, D., Kaluđerović, G. N., Mihajlović, E., Predarska, I., Dunđerović, D., Hey-Hawkins, E., Mijatović, S., & Maksimović-Ivanić, D.
(2025). Hybrid Platinum(IV)-Naproxen Nanostructured Drugs Reprogram Melanoma Cells and Overpower Cisplatin. Nanomaterials, 15(17), 1320.
https://doi.org/10.3390/nano15171320